首页> 外文OA文献 >The Transnational Governance of Synthetic Biology: Scientific uncertainty, cross-borderness and the ‘art’ of governance. For the Royal Society Science Policy Centre (UK).
【2h】

The Transnational Governance of Synthetic Biology: Scientific uncertainty, cross-borderness and the ‘art’ of governance. For the Royal Society Science Policy Centre (UK).

机译:合成生物学的跨国治理:科学的不确定性,跨界性和治理的“艺术”。英国皇家学会科学政策中心。

摘要

Synthetic biology is a new field of research that aims to 'make biology easier to engineer'. Some claimudthat it could revolutionise biotechnology to deliver applications for the energy, medical andudagricultural sectors. However there are concerns about potential environmental and health risks, theudcreation of monopolies dominated by large multinational corporations, and the ethics of creatingudartificial life. How should synthetic biology be best governed to maximise benefits and minimiseudrisks? In the last seven years, some 40 reports (in the English language alone) have addressed theudsocial, ethical and legal issues raised by synthetic biology. This Working Paper, based on an extensiveudliterature review and fieldwork in the UK, China and Japan, BIOS proposes a radical new approach toudthese issues.
机译:合成生物学是一个新的研究领域,旨在“使生物学更易于设计”。有人声称它会彻底改变生物技术,为能源,医疗和农业部门提供应用。然而,人们担心潜在的环境和健康风险,大型跨国公司主导的垄断的剥削以及创造人造生活的道德观。如何最好地控制合成生物学,以最大程度地提高收益并最大程度地降低/降低风​​险?在过去的七年中,大约有40份报告(仅英语)就解决了合成生物学提出的 udical,社会,道德和法律问题。本工作文件基于在英国,中国和日本的广泛文学评论和实地考察,BIOS提出了解决这些问题的全新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号